Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
India CDMO Market size was valued at US$ X million in 2024 and is expected to reach US$ X million by 2031, growing at a significant CAGR of X% from 2025-2031. The market report provides a detailed overview of the Indian CDMO Market, which has been segmented by application. Based on application, the India CDMO is segmented into CRO (Discovery, Preclinical, Clinical, Laboratory Services) and CMO (Finished Product Manufacturing, API Manufacturing, Packaging). According to precision business insights, the API Manufacturing segment is predicted to register the fastest growth rate during the forecast period.
In May 2019, Catalent Inc. acquired Paragon Bio Services, a leader in Gene Therapy.
The rising prevalence of chronic diseases and an increase in the geriatric population have boosted the demand for medical products with a shorter time to market, and quicker regulatory approval, which is expected to create demand for pharmaceuticals and the CDMO market in India.
|
Report Benchmarks |
Details |
|
By Service |
|
Download Free Sample Report
India cdmo market size was valued at US$ X million in 2024 and is expected to reach US$ X million by 2031, growing at a significant CAGR of X%.
The major players in the market are Albany Molecular Research Inc. (AMRI), Baxter, Covance Inc., PAREXEL International Corporation, Pharmaceutical Product Development LLC, Quanticate Ltd., SGS Life Science Services SA, Thermo Fisher Scientific Inc. (Patheon), Vetter, and Recipharm to name a few.
The segments of the market are Service.
| 1. Executive Summary |
| 2. India CDMO Market Introduction |
| 2.1. India CDMO Market - Taxonomy |
| 2.2. India CDMO Market- Definitions |
| 2.2.1. By Service |
| 3. India CDMO Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. India CDMO Market Dynamic Factors - Impact Analysis |
| 3.6. India CDMO Market Competition Landscape |
| 4. India CDMO Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. India CDMO Market, By Service, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.1. By CRO |
| 5.1.1. Discovery |
| 5.1.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Preclinical |
| 5.1.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.1.3. Clinical |
| 5.1.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3.3. Market Opportunity Analysis |
| 5.1.4. Laboratory Services |
| 5.1.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.4.3. Market Opportunity Analysis |
| 5.2. By CMO |
| 5.2.1. Finished Product Manufacturing |
| 5.2.1.1. Injectables |
| 5.2.1.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.2.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.1.3. Market Opportunity Analysis |
| 5.2.1.2. Solid Dosage Forms |
| 5.2.1.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.2.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.2.3. Market Opportunity Analysis |
| 5.2.1.3. Others (Semisolids/liquid, powder) |
| 5.2.1.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.2.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3.3. Market Opportunity Analysis |
| 5.2.2. API Manufacturing |
| 5.2.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 5.2.3. Packaging |
| 5.2.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3.3. Market Opportunity Analysis |
| 6. Competition Landscape |
| 6.1. Strategic Dashboard of Top Market Players |
| 6.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 6.2.1. Albany Molecular Research Inc. (AMRI) |
| 6.2.2. Baxter |
| 6.2.3. Covance Inc. |
| 6.2.4. PAREXEL International Corporation |
| 6.2.5. Pharmaceutical Product Development LLC |
| 6.2.6. Quanticate Ltd. |
| 6.2.7. SGS Life Science Services SA |
| 6.2.8. Thermo Fisher Scientific Inc. (Patheon) |
| 6.2.9. Vetter |
| 6.2.10. Recipharm |
| 7. Research Methodology |
| 8. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.